Sa354 OUTCOMES OF NASH CIRRHOSIS IN TYPE 2 DIABETICS TREATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS: A NATIONWIDE STUDY

Authors :: Na Li
chienwei chiang
Khalid Mumtaz
Kyle Porter
Stephen A. Firkins
Source :: Gastroenterology. 160:S-832
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: medicine.medical_specialty
Cirrhosis
Endocrinology
Hepatology
business.industry
Internal medicine
Gastroenterology
medicine
business
medicine.disease
Receptor
Glucagon-like peptide-1

Full Text Access

Tools